Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 28,196 | 30,111 | 32,325 | 28,963 | 26,428 |
| Cost of Goods | 12,833 | 13,121 | 13,514 | 13,141 | 12,840 |
| Gross Profit | 15,363 | 16,990 | 18,811 | 15,822 | 13,588 |
| Operating Expenses | 30,832 | 31,317 | 30,443 | 27,591 | 27,213 |
| Operating Income | -14,636 | -14,206 | -11,118 | -11,628 | -12,785 |
| Interest Expense | 491 | 2,701 | 4,069 | 4,019 | 3,916 |
| Other Income | 231 | -8,516 | 172 | 117 | 256 |
| Pre-tax Income | -14,896 | -25,423 | -15,015 | -15,530 | -16,445 |
| Income Tax | -1,143 | 42 | -240 | -780 | -204 |
| Net Income Continuous | -13,753 | -25,465 | -14,775 | -14,750 | -16,241 |
| Net Income | $-13,753 | $-25,465 | $-14,775 | $-14,750 | $-16,241 |
| EPS Basic Total Ops | -0.20 | -0.44 | -0.35 | -0.38 | -0.42 |
| EPS Basic Continuous Ops | -0.20 | -0.44 | -0.36 | -0.38 | -0.42 |
| EPS Diluted Total Ops | -0.20 | -0.44 | -0.35 | -0.38 | -0.42 |
| EPS Diluted Continuous Ops | -0.20 | -0.44 | -0.36 | -0.38 | -0.42 |
| EBITDA(a) | $-10,926 | $-8,178 | $-4,405 | $-5,005 | $-6,458 |